Unfavorable Intermediate-Risk Prostate Cancer
Showing 1 - 25 of >10,000
Prostate Cancer Trial in New Haven (Relugolix 120 MG [Orgovyx], SBRT standard of care radiotherapy treatment)
Not yet recruiting
- Prostate Cancer
- Relugolix 120 MG [Orgovyx]
- SBRT standard of care radiotherapy treatment
-
New Haven, ConnecticutYale Cancer Center
Oct 26, 2023
Prostate Cancer, Cancer of the Prostate Trial in Saint Louis (device, radiation, drug)
Recruiting
- Prostate Cancer
- Cancer of the Prostate
- Ethos Varian treatment system
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 19, 2023
Prostatic Cancer Trial (High Dose Brachytherapy, Stereostatic Body Radiation Therapy)
Not yet recruiting
- Prostatic Cancer
- High Dose Brachytherapy
- Stereostatic Body Radiation Therapy
- (no location specified)
Mar 3, 2023
Prostate Cancer Trial in United States (Stereotactic Body Radiation Therapy (SBRT))
Recruiting
- Prostate Cancer
- Stereotactic Body Radiation Therapy (SBRT)
-
Basking Ridge, New Jersey
- +6 more
Feb 23, 2022
Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)
Not yet recruiting
- Prostate Cancer
- +4 more
- Olaparib
- LHRH agonist
- (no location specified)
Aug 10, 2022
ABlative Radiotherapy (for) Unfavorable Prostate Tumors
Recruiting
- Prostate Cancer
-
Monza, MB, ItalyRadiation Oncology, ASST Monza (University of Milan Bicocca)
Jul 21, 2022
Prostate Cancer Trial in France (Association of darolutamide and EBRT, Association of ADT and EBRT)
Not yet recruiting
- Prostate Cancer
- Association of darolutamide and EBRT
- Association of ADT and EBRT
-
Avignon, France
- +9 more
Apr 21, 2022
Adenocarcinoma of the Prostate Trial in Sacramento (Stereotactic Radiosurgical Boost, Casodex, Leuprolide)
Recruiting
- Adenocarcinoma of the Prostate
- Stereotactic Radiosurgical Boost
- +2 more
-
Sacramento, CaliforniaUC Davis Sacramento Cancer Center Dept of Radiation Oncology
Sep 24, 2021
Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8, Stage IIA Prostate
Active, not recruiting
- Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8
- +8 more
- Computed Tomography
- +3 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Feb 10, 2022
Prostate Cancer Trial in Boston, Philadelphia (NBTXR3 activated by IMRT only, NBTXR3 activated by Brachytherapy & IMRT)
Terminated
- Prostate Cancer
- NBTXR3 activated by IMRT only
- NBTXR3 activated by Brachytherapy & IMRT
-
Boston, Massachusetts
- +1 more
May 5, 2021
Prostate Cancer, Prostate Adenocarcinoma Trial in Charlottesville (External Beam Radiation, HDR Brachytherapy, Androgen
Recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- External Beam Radiation
- +2 more
-
Charlottesville, VirginiaUniversity of Virginia
Oct 23, 2020
Prostate Cancer Trial (Piflufolastat F 18 Intravenous Solution [PYLARIFY])
Not yet recruiting
- Prostate Cancer
- Piflufolastat F 18 Intravenous Solution [PYLARIFY]
- (no location specified)
Oct 3, 2023
Localized Prostate Carcinoma, Castration-Naive Prostate Cancer, Intermediate Risk Prostate Cancer Trial in Turku (Degarelix,
Not yet recruiting
- Localized Prostate Carcinoma
- +3 more
- Degarelix
- MRI-guided transurethral ultrasound ablation (TULSA)
-
Turku, Southwest Finland, FinlandTurku University Hospital
Jun 14, 2023
Prostate Cancer Trial in Guangzhou ([18F]Florastamin Injection)
Recruiting
- Prostate Cancer
- [18F]Florastamin Injection
-
Guangzhou, ChinaSun Yat-sen University Cancer Center
Aug 21, 2023
PROSTATE CANCER Trial in Petah Tikva (Two-fraction stereotactic radiotherapy, Five-fraction stereotactic radiotherapy)
Recruiting
- PROSTATE CANCER
- Two-fraction stereotactic radiotherapy
- Five-fraction stereotactic radiotherapy
-
Petah Tikva, IsraelDavidoff Cancer Center, Rabin Medical Center
Sep 7, 2023
Prostate Cancer Trial in Cincinnati (Apalutamide Oral Product, Androgen Deprivation Therapy (ADT), Focal Therapy)
Not yet recruiting
- Prostate Cancer
- Apalutamide Oral Product
- +2 more
-
Cincinnati, OhioUniversity of Cincinnati Medical Center
Mar 27, 2023
Localized Prostate Cancer, Low Risk Prostate Cancer, Intermediate Risk Prostate Cancer Trial (3 fractions of prostate SBRT)
Not yet recruiting
- Localized Prostate Cancer
- +2 more
- 3 fractions of prostate SBRT
- (no location specified)
Oct 31, 2023
Prostate Cancer Trial (Vanquish System)
Not yet recruiting
- Prostate Cancer
- Vanquish System
- (no location specified)
Jan 16, 2023
Prostate Cancer Trial in Roma (Soractelite Echolaser Transperineal focal laser ablation)
Recruiting
- Prostate Cancer
- Soractelite Echolaser Transperineal focal laser ablation
-
Roma, RM, ItalySan Carlo di Nancy Hospital
Oct 16, 2022
Prostate Cancer Trial in Chapel Hill (68Ga-HBED-CC-PSMA)
Recruiting
- Prostate Cancer
-
Chapel Hill, North CarolinaUniversity of North Carolina - Chapel Hill
Jan 31, 2023
Prostate Cancer Trial in Candiolo (Robotic hemi-prostatectomy with urethral preservation)
Recruiting
- Prostate Cancer
- Robotic hemi-prostatectomy with urethral preservation
-
Candiolo, TO, ItalyFondazione del Piemonte per l'Oncologia
Apr 16, 2023
Prostate Cancer Trial in New York (IRE & MRgRT)
Recruiting
- Prostate Cancer
- IRE & MRgRT
-
New York, New YorkWeill Cornell Medicine
Aug 1, 2022
Prostate Cancer Trial (SUPR-SABR treatment)
Not yet recruiting
- Prostate Cancer
- SUPR-SABR treatment
- (no location specified)
Dec 20, 2022
Prostate Cancer Trial in Cairo (Prostate Only Radiation, Prostate and Pelvic Lymph Node Radiation)
Recruiting
- Prostate Cancer
- Prostate Only Radiation
- Prostate and Pelvic Lymph Node Radiation
-
Cairo, EgyptNational Cancer Institute - Cairo University
Aug 9, 2022